AU2020379762A1 - TREM compositions for con-rare codons and related uses - Google Patents

TREM compositions for con-rare codons and related uses Download PDF

Info

Publication number
AU2020379762A1
AU2020379762A1 AU2020379762A AU2020379762A AU2020379762A1 AU 2020379762 A1 AU2020379762 A1 AU 2020379762A1 AU 2020379762 A AU2020379762 A AU 2020379762A AU 2020379762 A AU2020379762 A AU 2020379762A AU 2020379762 A1 AU2020379762 A1 AU 2020379762A1
Authority
AU
Australia
Prior art keywords
trem
con
fragment
seq
codon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2020379762A
Other languages
English (en)
Inventor
Noubar Boghos Afeyan
Theonie ANASTASSIADIS
David Arthur Berry
Christine Elizabeth HAJDIN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Flagship Pioneering Inc
Original Assignee
Flagship Pioneering Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Flagship Pioneering Inc filed Critical Flagship Pioneering Inc
Publication of AU2020379762A1 publication Critical patent/AU2020379762A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Detergent Compositions (AREA)
AU2020379762A 2019-11-04 2020-11-04 TREM compositions for con-rare codons and related uses Pending AU2020379762A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962930361P 2019-11-04 2019-11-04
US62/930,361 2019-11-04
PCT/US2020/058948 WO2021092064A1 (en) 2019-11-04 2020-11-04 Trem compositions for con-rare codons and related uses

Publications (1)

Publication Number Publication Date
AU2020379762A1 true AU2020379762A1 (en) 2022-05-26

Family

ID=73654885

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2020379762A Pending AU2020379762A1 (en) 2019-11-04 2020-11-04 TREM compositions for con-rare codons and related uses

Country Status (9)

Country Link
US (1) US20220364092A1 (cg-RX-API-DMAC10.html)
EP (1) EP4055163A1 (cg-RX-API-DMAC10.html)
JP (1) JP2023500116A (cg-RX-API-DMAC10.html)
KR (1) KR20220128611A (cg-RX-API-DMAC10.html)
CN (1) CN115003810A (cg-RX-API-DMAC10.html)
AU (1) AU2020379762A1 (cg-RX-API-DMAC10.html)
CA (1) CA3160097A1 (cg-RX-API-DMAC10.html)
MX (1) MX2022005362A (cg-RX-API-DMAC10.html)
WO (1) WO2021092064A1 (cg-RX-API-DMAC10.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2020004587A (es) 2017-11-02 2021-04-12 Univ Iowa Res Found Métodos de rescate de codones de paro mediante reasignación genética con ace-arnt.
JP7712270B2 (ja) 2019-11-01 2025-07-23 テバード バイオサイエンシズ インコーポレイテッド 未成熟終止コドン媒介障害を処置するための方法および組成物
US20230203510A1 (en) * 2020-05-29 2023-06-29 Flagship Pioneering Innovations Vi, Llc Trem compositions and methods relating thereto
EP4158032A2 (en) * 2020-05-29 2023-04-05 Flagship Pioneering Innovations VI, LLC Trem compositions and methods relating thereto

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5801030A (en) 1995-09-01 1998-09-01 Genvec, Inc. Methods and vectors for site-specific recombination
US6693086B1 (en) 1998-06-25 2004-02-17 National Jewish Medical And Research Center Systemic immune activation method using nucleic acid-lipid complexes
US20080318884A1 (en) * 2005-03-25 2008-12-25 The Uab Research Foundation Methods for Altering Gene Expression and Methods of Treatment Utilizing Same
GB0600948D0 (en) * 2006-01-18 2006-02-22 Univ Dundee Prevention/Treatment Of Ichthyosis Vulgaris, Atopy And Other Disorders
WO2010141851A1 (en) * 2009-06-05 2010-12-09 Salk Institute For Biological Studies Improving unnatural amino acid incorporation in eukaryotic cells
US9676810B2 (en) * 2010-07-08 2017-06-13 The Brigham And Women's Hospital, Inc. Neuroprotective molecules and methods of treating neurological disorders and inducing stress granules
KR102485491B1 (ko) * 2012-10-02 2023-01-04 벡션 테라퓨틱스 엘엘씨 면역 조절성 미니세포 및 사용 방법
BR112016011195A2 (pt) 2013-11-18 2017-09-19 Rubius Therapeutics Inc Células eritroides enucleadas e seus métodos de fabricação, composição farmacêutica e seu uso, uso de uma população de células eritroides, biorreator, mistura de células e dispositivo médico
CN106456744A (zh) 2014-04-01 2017-02-22 鲁比厄斯治疗法股份有限公司 用于免疫调节的方法和组合物
WO2016183482A1 (en) 2015-05-13 2016-11-17 Rubius Therapeutics, Inc. Membrane-receiver complex therapeutics
CN108697733A (zh) 2016-01-11 2018-10-23 鲁比厄斯治疗法股份有限公司 与癌症适应症的多模式治疗性细胞体系有关的组合物和方法
MX2019000205A (es) 2016-07-07 2019-09-23 Rubius Therapeutics Inc Composiciones y metodos relacionados con sistemas celulares terapeuticos que expresan arn exogeno.
BR112019011138A2 (pt) 2016-12-02 2019-10-01 Rubius Therapeutics, Inc. composições e métodos relacionados com sistemas celulares para penetração em tumores sólidos
CN110520522A (zh) 2017-02-17 2019-11-29 鲁比厄斯治疗法股份有限公司 功能化红系细胞
US11576872B2 (en) 2017-05-08 2023-02-14 Flagship Pioneering Innovations V, Inc. Compositions for facilitating membrane fusion and uses thereof
EA202190736A1 (ru) * 2018-09-26 2021-09-16 Кейс Вестерн Ризерв Юниверсити Способы и композиции для увеличения экспрессии белка и/или лечения расстройства, связанного с гаплонедостаточностью
IL284878B2 (en) * 2019-01-18 2026-04-01 Flagship Pioneering Inc TREM preparations and their uses
JP2022534988A (ja) * 2019-05-31 2022-08-04 フラッグシップ パイオニアリング, インコーポレイテッド tRNAプールを調節するためのTREMの使用

Also Published As

Publication number Publication date
KR20220128611A (ko) 2022-09-21
CA3160097A1 (en) 2021-05-14
EP4055163A1 (en) 2022-09-14
CN115003810A (zh) 2022-09-02
US20220364092A1 (en) 2022-11-17
MX2022005362A (es) 2022-09-23
JP2023500116A (ja) 2023-01-04
WO2021092064A1 (en) 2021-05-14

Similar Documents

Publication Publication Date Title
EP4055163A1 (en) Trem compositions for con-rare codons and related uses
WO2020243560A1 (en) Uses of trem compositions to modulate trna pools
US20220112489A1 (en) Trem compositions and uses thereof
JP2021500863A (ja) ゲノム編集用のポリヌクレオチド、組成物および方法
BR112021007025A2 (pt) composições e métodos para imunoterapia
CN120283052A (zh) 用于表观遗传调控hbv基因表达的组合物和方法
EP1976567A2 (en) Natural antisense and non-coding rna transcripts as drug targets
TW202102529A (zh) 用於多肽表現之多核苷酸、組合物及方法
US20230374456A1 (en) T-Cell Immunoglobulin and Mucin Domain 3 (TIM3) Compositions and Methods for Immunotherapy
WO2022012531A1 (zh) 一种经修饰的免疫细胞的制备方法
JP2023534304A (ja) Line1の阻害剤及びその使用
JP2024505678A (ja) 免疫療法のためのリンパ球活性化遺伝子3(lag3)組成物及び方法
JP2024505672A (ja) 免疫療法のためのナチュラルキラー細胞受容体2b4組成物及び方法
CN118660960A (zh) 用于基因组编辑的多核苷酸、组合物和方法
US20220364075A1 (en) Methods of modifying a nucleic acid sequence
HK40128700A (en) Compositions and methods for epigenetic regulation of hbv gene expression
EP4392060A1 (en) Programmed cell death protein 1 (pd1) compositions and methods for cell-based therapy
HK40058210A (en) Compositions and methods for immunotherapy
von Niessen Optimization of RNA cancer vaccines using 3’UTR sequences selected for stabilization of RNA Dissertation zur Erlangung des Grades Doktor der Naturwissenschaften